Stocks › CGON
CG Oncology CGON
US equityMarket cap rank #1717
$79.47 −$2.43 (-2.97%)
Market closed · Nov 22, 5:50 am ET · Last extended-hours $79.50 +0.04%
Open$80.32
Prev close$81.90
Day range$79.21 – $83.16
Volume1.67M
Market cap$7.10B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.60M-3.7% YoY
Operating profit-$63.25M-23.7% YoY
Net profit-$56.89M-29.9% YoY
Diluted EPS-$0.64-12.3% YoY
Free cash flow-$48.82M-25.2% YoY
Operating cash flow-$47.71M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin-104.8%
Operating margin-4,293.5%
Net margin-3,851.1%
Return on equity-28.3%
Return on assets-26.7%
Return on invested capital-31.3%
Current ratio21.70
Liabilities / assets5.3%
Cash & investments$984.46M
Total debt$8.11M
Net cash (debt)$976.35M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.60M | $1.16M | $1.08M | $4.04M | $2.32M |
| Total Operating Revenue | $1.60M | $1.16M | $1.08M | $4.04M | $2.32M |
| Cost of Revenue | $2.67M | $3.93M | $2.96M | $4.65M | $3.07M |
| Gross Profit | -$1.07M | -$2.77M | -$1.88M | -$607,000.00 | -$748,000.00 |
| Operating Expense | $62.18M | $83.63M | $64.51M | $190.17M | $47.95M |
| Selling and Admin Expenses | $22.96M | $28.98M | $20.78M | $73.53M | $17.99M |
| -General & Admin Expense | $22.96M | $28.98M | $20.78M | $73.53M | $17.99M |
| Research & Development | $39.22M | $54.66M | $43.73M | $116.64M | $29.96M |
| Operating Profit | -$63.25M | -$86.40M | -$66.39M | -$190.77M | -$48.70M |
| Net Non-Operating Interest Income (Expense) | $6.42M | $7.33M | $6.29M | $29.93M | $7.44M |
| Non-Operating Interest Income | $6.42M | $7.33M | $6.29M | $29.93M | $7.44M |
| Other Income (Expense) | -$65,000.00 | $16,000.00 | -$101,000.00 | -$152,000.00 | -$53,000.00 |
| Other Non-Operating Income (Expenses) | -$65,000.00 | $16,000.00 | -$101,000.00 | -$152,000.00 | -$53,000.00 |
| Pretax Profit | -$56.89M | -$79.06M | -$60.20M | -$161.00M | -$41.31M |
| Net Profit | -$56.89M | -$79.06M | -$60.20M | -$161.00M | -$41.31M |
| Profit from Continuing Operations | -$56.89M | -$79.06M | -$60.20M | -$161.00M | -$41.31M |
| Net Income to Parent Company | -$56.89M | -$79.06M | -$60.20M | -$161.00M | -$41.31M |
| Net Income to Common Stockholders | -$56.89M | -$79.06M | -$60.20M | -$161.00M | -$41.31M |
| Basic EPS | -$0.64 | -$0.90 | -$0.71 | -$2.08 | -$0.51 |
| Diluted EPS | -$0.64 | -$0.90 | -$0.71 | -$2.08 | -$0.51 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.05B | $1.09B | $1.14B | $791.59M | $791.59M |
| Total Current Assets | $1.01B | $1.05B | $1.10B | $759.48M | $759.48M |
| Cash and Cash Equivalents & Short-Term Investments | $984.46M | $1.03B | $1.08B | $742.16M | $742.16M |
| -Cash and Cash Equivalents | $28.25M | $19.64M | $33.70M | $32.49M | $32.49M |
| -Short Term Investments | $956.21M | $1.01B | $1.04B | $709.67M | $709.67M |
| Receivables | $666,000.00 | $417,000.00 | $1.28M | $688,000.00 | $688,000.00 |
| -Accounts Receivable | $666,000.00 | $417,000.00 | $1.28M | $688,000.00 | $688,000.00 |
| Inventory | $1.17M | $1.00M | $1.49M | $1.57M | $1.57M |
| Other Current Assets | $21.44M | $19.95M | $23.13M | $15.07M | $15.07M |
| Total Non-Current Assets | $38.94M | $36.01M | $33.12M | $32.12M | $32.12M |
| Net PPE | $21.19M | $20.44M | $19.59M | $19.57M | $19.57M |
| -Gross PPE | $25.15M | $23.57M | $21.88M | $21.04M | $21.04M |
| -Accumulated Depreciation | -$3.96M | -$3.13M | -$2.29M | -$1.47M | -$1.47M |
| Goodwill and Other Intangible Assets | $10.83M | $10.84M | $10.86M | $10.87M | $10.87M |
| -Goodwill | $10.30M | $10.30M | $10.30M | $10.30M | $10.30M |
| -Other Intangible Assets | $530,000.00 | $545,000.00 | $560,000.00 | $575,000.00 | $575,000.00 |
| Other Non-Current Assets | $6.92M | $4.73M | $2.68M | $1.68M | $1.68M |
| Total Liabilities | $55.70M | $56.54M | $43.48M | $38.99M | $38.99M |
| Total Current Liabilities | $46.43M | $47.24M | $35.22M | $30.84M | $30.84M |
| Payables | $9.77M | $12.73M | $8.24M | $5.71M | $5.71M |
| -Accounts Payable | $9.77M | $12.73M | $8.24M | $5.71M | $5.71M |
| Current Accrued Expenses | $26.68M | $26.27M | $20.95M | $14.90M | $14.90M |
| Short-Term Debt and Capital Lease Obligation | $1.13M | $985,000.00 | $1.07M | $915,000.00 | $915,000.00 |
| -Current Capital Lease Obligation | $1.13M | $985,000.00 | $1.07M | $915,000.00 | $915,000.00 |
| Current Deferred Liabilities | $29,000.00 | $226,000.00 | $254,000.00 | $286,000.00 | $286,000.00 |
| Other Current Liabilities | $1.56M | $1.45M | $1.71M | $802,000.00 | $802,000.00 |
| Total Non-Current Liabilities | $9.27M | $9.30M | $8.27M | $8.15M | $8.15M |
| Long Term Debt and Capital Lease Obligation | $8.11M | $7.83M | $6.51M | $6.11M | $6.11M |
| -Long Term Debt | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| -Long Term Capital Lease Obligation | $5.11M | $4.83M | $3.51M | $3.11M | $3.11M |
| Non-Current Deferred Liabilities | $307,000.00 | $307,000.00 | $307,000.00 | $307,000.00 | $307,000.00 |
| Other Non-Current Liabilities | $855,000.00 | $1.16M | $1.45M | $1.74M | $1.74M |
| Total Equity | $990.97M | $1.03B | $1.09B | $752.60M | $752.60M |
| Stockholders' Equity | $990.97M | $1.03B | $1.09B | $752.60M | $752.60M |
| Capital Stock | $9,000.00 | $9,000.00 | $9,000.00 | $8,000.00 | $8,000.00 |
| -Common Stock | $9,000.00 | $9,000.00 | $9,000.00 | $8,000.00 | $8,000.00 |
| Additional Paid-In Capital | $1.57B | $1.55B | $1.53B | $1.13B | $1.13B |
| Retained Earnings | -$575.13M | -$518.23M | -$439.18M | -$378.98M | -$378.98M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$47.71M | -$46.41M | -$56.94M | -$132.35M | -$36.22M |
| Net cash flow from continuing operations | -$47.71M | -$46.41M | -$56.94M | -$132.35M | -$36.22M |
| Net Income from Continuing Operations | -$56.89M | -$79.06M | -$60.20M | -$161.00M | -$41.31M |
| Depreciation & Depletion & Amortization | $1.16M | $850,000.00 | $841,000.00 | $1.45M | $849,000.00 |
| Other Non-Cash Items | $110,000.00 | $71,000.00 | $59,000.00 | -$734,000.00 | $89,000.00 |
| Change in Working Capital | -$5.82M | $14.38M | -$5.78M | $2.28M | -$3.98M |
| -Change in Receivables | -$249,000.00 | $858,000.00 | -$587,000.00 | -$320,000.00 | -$301,000.00 |
| -Change in Inventory | -$162,000.00 | $490,000.00 | $72,000.00 | -$444,000.00 | -$64,000.00 |
| -Change in Prepaid Assets | -$1.49M | $3.18M | -$8.07M | -$1.90M | -$1.81M |
| -Change in Payables and Accrued Expense | -$974,000.00 | $12.23M | $4.13M | $7.01M | $252,000.00 |
| -Change in Other Current Assets | -$2.62M | -$2.05M | -$998,000.00 | -$1.58M | -$1.56M |
| -Change in Other Current Liabilities | -$324,000.00 | -$325,000.00 | -$329,000.00 | -$487,000.00 | -$496,000.00 |
| Net cash flow from investing | $46.04M | $30.43M | -$334.85M | -$245.82M | -$75.51M |
| Net Cash Flow from Continuing Investing Activities | $46.04M | $30.43M | -$334.85M | -$245.82M | -$75.51M |
| Net PPE Purchase and Sale | -$1.12M | -$468,000.00 | -$304,000.00 | -$134,000.00 | -$7,000.00 |
| Net Investment Purchase and Sale | $47.15M | $30.90M | -$334.54M | -$223.72M | -$75.50M |
| Financing Cash Flow | $10.28M | $1.92M | $393.00M | $153.59M | $99.07M |
| Net Cash Flow from Continuing Financing Activities | $10.28M | $1.92M | $393.00M | $153.59M | $99.07M |
| Net Common Stock Issuance | $0.00 | $0.00 | $391.55M | $147.45M | $98.45M |
| Proceeds from Stock Option Exercised | $10.29M | $2.08M | $1.67M | $6.46M | $656,000.00 |
| Net Other Financing Charges | -$3,000.00 | -$159,000.00 | -$221,000.00 | -$316,000.00 | -$39,000.00 |
| Ending Cash Balance | $28.25M | $19.64M | $33.70M | $32.49M | $32.49M |
| Net Change in Cash | $8.61M | -$14.06M | $1.21M | -$224.58M | -$12.66M |
| Beginning Cash Balance | $19.64M | $33.70M | $32.49M | $257.07M | $45.15M |
| Free Cash Flow | -$48.82M | -$46.88M | -$57.25M | -$132.48M | -$36.22M |
| Net Business Purchase and Sale | – | – | – | -$21.97M | $0.00 |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | $0.00 |
| Net Preferred Stock Issuance | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on CGON.
Sign in to join the discussion.